Femroz 2.5 mg by Everest Pharmaceuticals Ltd., Bangladesh, contains letrozole 2.5 mg, the same active ingredient and strength as the originator brand Femara 2.5 mg (Novartis). It is a prescription aromatase inhibitor used in the hormonal treatment of certain breast cancers in postmenopausal women.

Originator reference: Femara (Novartis)
Listed alternative brand: Femroz (Everest Pharmaceuticals)
Generic: Letrozole 2.5 mg
Form: Oral tablet
Prescription: Required

Shared ingredients and strength do not establish bioequivalence or automatic interchangeability. Any substitution must be approved by a qualified healthcare professional.